# FACBC for Head and Neck Cancers

> **NCT01933269** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Emory University**

## Conditions studied

- Cancers of the Head and Neck

## Interventions

- **DRUG:** FACBC

## Key facts

- **NCT ID:** NCT01933269
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-05
- **Primary completion:** 2018-02-01
- **Final completion:** 2018-02-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Change in Principal Investigator and protocol revisions delayed study start and ultimately the decision was made to cancel the study.
- **Last updated:** 2018-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01933269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01933269, "FACBC for Head and Neck Cancers". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01933269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*